Similar articles

• [A history and prospect of adoptive immunotherapy against malignant glioma--past, now and future].

  Nitta T. Nitta T. No To Shinkei. 1992 Jul;44(7):605-13. No To Shinkei. 1992. PMID: 1419336 Review. Japanese. No abstract available.
• Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response.

  Tsugawa T, Kuwashima N, Sato H, Fellows-Mayle WK, Dusak JE, Okada K, Papworth GD, Watkins SC, Gambotto A, Yoshida J, Pollack IF, Okada H. Tsugawa T, et al. Gene Ther. 2004 Nov;11(21):1551-8. doi: 10.1038/sj.gt.3302300. Gene Ther. 2004. PMID: 15343358
• Immunotherapy with stimulated autologous lymphocytes in a case of a juvenile anaplastic glioma.

  Thomas C, Schober R, Lenard HG, Lumenta CB, Jacques DB, Wechsler W. Thomas C, et al. Neuropediatrics. 1992 Jun;23(3):123-5. doi: 10.1055/s-2008-1071326. Neuropediatrics. 1992. PMID: 1641079
• [Dendritic cell therapy for malignant glioma].

  Yamanaka R, Homma J, Yajima N, Tsuchiya N, Tanaka R. Yamanaka R, et al. No To Shinkei. 2003 Sep;55(9):771-80. No To Shinkei. 2003. PMID: 14571839 Review. Japanese.
• [Cellular immunotherapy for hematological malignancies].

  Yasukawa M. Yasukawa M. Rinsho Ketsueki. 2008 Oct;49(10):1460-71. Rinsho Ketsueki. 2008. PMID: 18833930 Review. Japanese. No abstract available.